Direct-to-patient BRCA1 testing: the Twoj Styl experience
Computed tomography in suspected local breast cancer recurrence
Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy
Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19
Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer
Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study
Cigarette smoking and breast cancer risk: update of a prospective cohort study
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806
Variation in false-positive rates of mammography reading among 1067 radiologists: a population-based assessment
Is risk of axillary lymph node metastasis associated with proximity of breast cancer to the skin?
Albumin-bound paclitaxel, ABI-007 may show better efficacy than paclitaxel in basal-like breast cancers: association between caveolin-1 expression and ABI-007
Lack of association between NOS3 Glu298Asp and breast cancer risk: a case-control study
A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene
Central review of Er, PgR and HER-2 in BIG 1-98 evaluating letrozole versus tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer
Ki67 after 2 weeks endocrine treatment predicts relapse-free survival (RFS) in the IMPACT trial
Trastuzumab sensitivity of breast cancer with co-amplification of HER2 and cMYC suggests pro-apoptotic function of dysregulated cMYC in vivo
Genetically engineered human breast tumors in mice
Phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in patients with axillary node-positive or high-risk node-negative breast cancer: results of North American Breast Cancer Intergroup Trial E1199
A phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy
Human papillomavirus type 16 transform non-invasive breast cancer cells to invasive cells
Shc proteins in primary breast tumors predict outcome in treatment naïve, tamoxifen-treated and chemotherapy-treated patients
Influence of hormone receptor status on axillary lymph node (ALN) pathologic complete response (pCR) rates in patients with cytologically confirmed ALN metastases prior to primary chemotherapy for breast cancer
Validity of DNA-methylation marker PITX2 to predict risk of recurrence in lymph node-negative hormone receptor-positive breast cancer patients: a transfer study
Serum profiling predictive of invasive breast cancer
Concurrence of contralateral breast cancers for estrogen and progesterone receptor status and mode of detection
Using AQUA™ and tissue microarrays for discovery of a minimal set of multiplexed markers to subclassify breast cancer
Expression of leptin and leptin receptor in breast cancer are associated with aggressive histology, distant recurrence and survival
The SNP309 HDM2 polymorphism is associated with chemoresistance and poor survival in breast cancers harboring mutations in the TP53 gene
The effect of silencing the insulin-like growth factor receptor on tamoxifen sensitive and tamoxifen resistant breast cancer cells
Long term culture of MCF-7 breast cancer cells with small interfering RNA to the insulin-like growth factor receptor causes decreased cell proliferation
Inhibition of MAPK restores anti-estrogen response in vitro and ERa expression in breast tumors
The effects of relaxation guided imagery on natural killer (NK) cell and cytokine IL-2 induced NK cytotoxicity in breast cancer patients
The effectiveness of per-operative use of human surgical sealant-'Quixil' in reducing the post operative seroma formation in breast cancer patients
The incidence of axillary nodal metastases in older women with small non-high grade breast tumours
A standardized surgical technique for mastoscopic axillary lymph node dissection
Role of hypoxia-inducible factor 1 in predicting treatment efficacy in primary chemo-endocrine therapy in human breast cancer
Src as a novel molecular biomarker for response to neoadjuvant chemotherapy with sequential doxorubicin and docetaxel in high-risk breast cancer
Plasma kinetics and uptake of a cholesterol-rich microemulsion (LDE) associated to a derivative paclitaxel by neoplastic breast tissue
C-MYC expression correlates with atypia and malignancy in early breast lesions associated with microcalcifications detected by routine mammography
Variation in protein expression patterns of nipple aspirate fluid comparing women with breast cancer and healthy women using time-of-flight mass spectrometry
Comparison of FLT-(18F) and FDG-(18F) to visualize cancer spread while staging locally advanced breast cancer with PET/CT: preliminary data
Concordance of HER2 and hormone receptor expression in primary and recurrent breast cancer
Impact of letrozole on quality of life in postmenopausal women with early breast cancer: does age matter?
p53 codom 72 polymorphism and the correlation with breast cancer
Diet and global DNA methylation in breast cancer
Using AQUA™ and tissue microarrays for discovery of a minimal set of multiplexed markers to subclassify breast cancer
The androgen receptor gene polymorphisms in human breast cancer: short CAG repeats are associated with lymph node involvement
Plakoglobin (g-catenin) is a prognostic marker in breastcancer
Gene expression profile of ATP binding cassette (ABC)transporter in breast cancer patient in relation to the response to neoadjuvant chemotherapy
Bone turnover by osteocalcin and risks of breast cancer and fracture: a prospective study
Inhibition of PCDGF/GP88 expression by SiRNA restores tamoxifen responsiveness in tamoxifen resistant breast cancer cells
The phytoestrogen resveratrol acts opposite of estrogen to inhibit migration and differentially signal to the actin cytoskeleton of metastatic breast cancer cells
Glyceollins (I-III), novel anti-estrogenic phytochemicals isolated from soy
Morphological and immunohistochemical aspects of the breast tissue in postmenopausal women before and after hormone replacement therapy
Transfer of lipids to HDL in patients with breast cancer
Risk factors in breast cancer, a myth-an Indian experience
Prediction of axillary sentinel node status: study of a large single institution series of breast cancer patients
Efficacy and safety of intravenous ibandronate 6 mg infused over 15 min: results from a 2-year study of breast cancer patients with metastatic bone disease
Decision criteria for adjuvant chemotherapy or hormonal therapy in node negative breast cancer: results of a french oncologist survey
One year outcomes of an early identification and intervention model to reduce upper extremity morbidity related to breast cancer treatment
The loss of 14-3-3 sigma (s) protein expression in invasive adenocarcinoma of the breast is associated with promoter hypermethylation and a more favorable clinical outcome
(18)F flurothymidine (FLT) for imaging of tumor cell proliferation; an in vitro-study for monitoring chemoendocrine treatment in breast cancer cells
The role of the JNK signaling pathway in breast cancer cell lines